AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliclafin M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Q Check Speciality Care

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gliclafin M 80mg/500mg Tablet

Diabetac Duo 80mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation aids in regulating blood glucose. Diabetac Duo 80mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods or juice) is essential to manage hypoglycemia. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before starting treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are typically recommended.

Primary Ingredients of Gliclafin M 80mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Gliclafin M 80mg/500mg Tablet

Diabetes mellitus type 2

Major Benefits of Gliclafin M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 80mg/500mg Gliclafin M tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with food.

Common Side effects of Gliclafin M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclafin M 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclafin M 80mg/500mg tablets should be administered with a meal.

How Gliclafin M 80mg/500mg Tablet works:

Gliclazide and Metformin, combined as Gliclafin M 80mg/500mg tablets, offer dual action against diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Gliclafin M 80mg/500mg tablets is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliclafin M 80mg/500mg tablets during pregnancy is contraindicated due to confirmed risk to the fetus. A physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gliclafin M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Gliclafin M 80mg/500mg tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliclafin M 80mg/500mg tablets. Physician consultation is recommended. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Gliclafin M 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low starting dose is typically recommended; however, Gliclafin M 80mg/500mg tablets are unsuitable for patients exhibiting severe hepatic dysfunction.

What if you forget to take Gliclafin M 80mg/500mg Tablet :

Should you forget to take your Gliclafin M 80mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliclafin M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliclafin M 80mg/500mg Tablet

Gliclafin M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliclafin M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclafin M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclafin M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA – Metformin-associated lactic acidosis) resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclafin M 80mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Gliclafin M 80mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Gliclafin M 80mg/500mg Tablets are contraindicated in patients with allergies to any of its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining alcohol and Gliclafin M 80mg/500mg tablets is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the likelihood of lactic acidosis.
Gliclafin M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is unsuitable for type 1 diabetes.
Gliclafin M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclafin M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), resulting in symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Gliclafin M 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those consuming excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Gliclafin M 80mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Gliclafin M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and Gliclafin M 80mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Gliclafin M 80mg/500mg Ta...
84
MRP 103
18% off